Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022
Illumina, Inc. (NASDAQ: ILMN) will release its fourth quarter and full year 2021 financial results on February 10, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina, Inc. (NASDAQ: ILMN) will release its fourth quarter and full year 2021 financial results on February 10, 2022, after market close. The company's President and CEO, Francis deSouza, along with CFO Sam Samad, will host a conference call at 2:00 PM PT to discuss the results. Investors can access this call via Illumina's website or by dialing in. A replay will be available for 30 days post-event. Illumina focuses on enhancing health through genomic innovation and is a leader in DNA sequencing technologies.
Positive
- Scheduled announcement of fourth quarter and full year 2021 financial results, indicating transparency.
- Opportunity for investors to engage directly with leadership during the conference call.
Negative
- None.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was -3.81%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Jan. 20, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it will issue results for the fourth quarter and full year 2021 following the close of market on Thursday, February 10, 2022.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, February 10, 2022. Interested parties may access the live teleconference through the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. Alternatively, individuals can access the call by dialing 1 (844) 200-6205 or 1 (929) 526-1599 outside North America, both with Conference ID 018314. To ensure timely connection, please dial in at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-fourth-quarter--full-year-2021-financial-results-on-thursday-february-10-2022-301465338.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.